Apollo Health Ventures invests in early‑stage biotechnology and health‑technology companies that aim to prevent or treat age‑related diseases and extend healthy lifespan. They focus on transformative therapeutics, data platforms, and health‑tech solutions that address the underlying biology of aging, often partnering with leading scientists and research institutions. Their model combines venture‑building with traditional VC funding to create and scale breakthrough healthcare companies.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
GermanyLuxembourgUnited States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
40.0%Germany
20.0%Switzerland
20.0%United Kingdom
20.0%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Pre-Seed → Series B
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Debut Secondaries Fund
Vintage 2025 • $5.4B